Yuwon Kim

Yuwon Kim

Auto-generated profile, based on publicly available information

Yuwon Kim

Department of Applied Artificial Intelligence, Seoul National University of Science and Technology, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
BPBogyeom Park
Bogyeom Park
YKYuwon Kim
Yuwon Kim
JPJinseok Park
Jinseok Park
HCHojin Choi
Hojin Choi
SKSeong-Eun Kim
Seong-Eun Kim
KSKyoungwon Seo
Kyoungwon Seo
Background: Early detection of mild cognitive impairment (MCI), a transitional stage between normal aging and Alzheimer disease, is crucial for preventing the progression of dementia. Virtual reality (VR) biomarkers have proven to be effective in capturing behaviors associated with subtle deficits in instrumental activities of daily living, such as challenges in using a food-ordering kiosk, for early detection of MCI. On the other hand, magnetic resonance imaging (MRI) biomarkers have demonstrated their efficacy in quantifying observable structural brain changes that can aid in early MCI detection. Nevertheless, the relationship between VR-derived and MRI biomarkers remains an open question. In this context, we explored the integration of VR-derived and MRI biomarkers to enhance early MCI detection through a multimodal learning approach. Objective: We aimed to evaluate and compare the efficacy of VR-derived and MRI biomarkers in the classification of MCI while also examining the strengths and weaknesses of each approach. Furthermore, we focused on improving early MCI detection by leveraging multimodal learning to integrate VR-derived and MRI biomarkers. Methods: The study encompassed a total of 54 participants, comprising 22 (41%) healthy controls and 32 (59%) patients with MCI. Participants completed a virtual kiosk test to collect 4 VR-derived biomarkers (hand movement speed, scanpath length, time to completion, and the number of errors), and T1-weighted MRI scans were performed to collect 22 MRI biomarkers from both hemispheres. Analyses of covariance were used to compare these biomarkers between healthy controls and patients with MCI, with age considered as a covariate. Subsequently, the biomarkers that exhibited significant differences between the 2 groups were used to train and validate a multimodal learning model aimed at early screening for patients with MCI among healthy controls. Results: The support vector machine (SVM) using only VR-derived biomarkers achieved a sensitivity of 87.5% and specificity of 90%, whereas the MRI biomarkers showed a sensitivity of 90.9% and specificity of 71.4%. Moreover, a correlation analysis revealed a significant association between MRI-observed brain atrophy and impaired performance in instrumental activities of daily living in the VR environment. Notably, the integration of both VR-derived and MRI biomarkers into a multimodal SVM model yielded superior results compared to unimodal SVM models, achieving higher accuracy (94.4%), sensitivity (100%), specificity (90.9%), precision (87.5%), and F1-score (93.3%). Conclusions: The results indicate that VR-derived biomarkers, characterized by their high specificity, can be valuable as a robust, early screening tool for MCI in a broader older adult population. On the other hand, MRI biomarkers, known for their high sensitivity, excel at confirming the presence of MCI. Moreover, the multimodal learning approach introduced in our study provides valuable insights into the improvement of early MCI detection by integrating a diverse set of biomarkers.

11 May 2024
Verified
Conference Paper
Open access
YKYuwon Kim
Yuwon Kim
JPJinseok Park
Jinseok Park
HCHojin Choi
Hojin Choi
MLMartin Loeser
Martin Loeser
HRHokyoung Ryu
Hokyoung Ryu
KSKyoungwon Seo
Kyoungwon Seo
The imperative for early mild cognitive impairment (MCI) detection is underscored by the limitations of traditional biomarkers, high cost and invasiveness, and they often fail to capture behavioral changes in MCI patients associated with impaired instrumental activities of daily living (IADL). This study introduces a cost-effective, non-invasive alternative using digital markers, “virtual kiosk test”, which involves performing IADL tasks such as ordering food via a kiosk in virtual reality (VR) to detect MCI at an early stage. Involving 20 healthy controls and 31 MCI patients, four key behavioral features within VR digital markers effectively differentiate groups: hand movement speed, proportion of fixation duration, time to completion, and the number of errors. A machine learning model demonstrated high effectiveness with 93.3% accuracy, 100% sensitivity, 83.3% specificity, 90% precision, and a 94.7% F1-score in group differentiation. Findings suggest that observing behaviors via the virtual kiosk test within 5 minutes can be an efficient approach for early MCI detection, acting as reliable VR digital markers.

30 May 2024 in Sensors
Verified
Journal Article
Open access
PDF file
DKDohyun Kim
Dohyun Kim
YKYuwon Kim
Yuwon Kim
JPJinseok Park
Jinseok Park
HCHojin Choi
Hojin Choi
HRHokyoung Ryu
Hokyoung Ryu
KSKyoungwon Seo
Kyoungwon Seo
Amnestic mild cognitive impairment (aMCI) is a transitional stage between normal aging and Alzheimer’s disease, making early screening imperative for potential intervention and prevention of progression to Alzheimer’s disease (AD). Therefore, there is a demand for research to identify effective and easy-to-use tools for aMCI screening. While behavioral tests in virtual reality environments have successfully captured behavioral features related to instrumental activities of daily living for aMCI screening, further investigations are necessary to establish connections between cognitive decline and neurological changes. Utilizing electroencephalography with steady-state visual evoked potentials, this study delved into the correlation between behavioral features recorded during virtual reality tests and neurological features obtained by measuring neural activity in the dorsal stream. As a result, this multimodal approach achieved an impressive screening accuracy of 98.38%.

11 May 2024
Verified
Conference Paper
Open access
BPBoGyeom Park
BoGyeom Park
YKYuwon Kim
Yuwon Kim
JPJinseok Park
Jinseok Park
HCHojin Choi
Hojin Choi
SKSeong-Eun Kim
Seong-Eun Kim
KSKyoungwon Seo
Kyoungwon Seo
Early detection of mild cognitive impairment (MCI) is crucial to impede dementia progression. Virtual reality (VR) biomarkers are adept at detecting impairments in instrumental activities of daily living (IADL), whereas magnetic resonance imaging (MRI) biomarkers excel in measuring observable structural changes in the brain. However, the efficacy of integrating VR and MRI biomarkers to improve early MCI detection remains unclear. This study aims to evaluate and compare the effectiveness of VR and MRI biomarkers and investigates the potential of their combined use for more accurate early MCI detection. Through support vector machine analysis, distinct characteristics were observed. For identifying MCI, VR biomarkers demonstrated high specificity (90.0%), whereas MRI showed high sensitivity (90.9%). The combination of both biomarkers yielded superior results in accuracy (94.4%), sensitivity (100.0%), and specificity (90.9%). Drawing from these results, we suggest a sequential diagnostic approach, employing VR for initial screening and MRI for subsequent confirmation of MCI.